Piotr Tomczak
Poznan University of Medical Sciences(PL)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Renal and related cancers, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Theoretical and Computational Physics
Most-Cited Works
- → Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma(2007)5,732 cited
- → Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma(2007)3,641 cited
- → Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma(2009)2,185 cited
- → Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial(2011)1,839 cited
- → Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer(2004)1,701 cited
- → Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer(2010)883 cited